Cisplatin or carboplatin for the treatment of non-small cell lung cancer: do they have equivalent efficacy?

被引:8
作者
Berghmans, T [1 ]
Paesmans, M [1 ]
Sculier, JP [1 ]
机构
[1] Inst Jules Bordet, Dept Med, B-1000 Brussels, Belgium
关键词
D O I
10.1016/S0169-5002(01)00240-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:15 / 17
页数:3
相关论文
共 6 条
[1]   Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study [J].
Jelic, S ;
Mitrovic, L ;
Radosavljevic, D ;
Elezar, E ;
Babovic, N ;
Kovcin, V ;
Tomasevic, Z ;
Kovacevic, S ;
Gavrilovic, D ;
Radulovic, S .
LUNG CANCER, 2001, 34 (01) :1-13
[2]   A RANDOMIZED STUDY COMPARING CISPLATIN OR CARBOPLATIN WITH ETOPOSIDE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER - EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER PROTOCOL 07861 [J].
KLASTERSKY, J ;
SCULIER, JP ;
LACROIX, H ;
DABOUIS, G ;
BUREAU, G ;
LIBERT, P ;
RICHEZ, M ;
RAVEZ, P ;
VANDERMOTEN, G ;
THIRIAUX, J ;
CORDIER, R ;
FINET, C ;
BERCHIER, MC ;
SERGYSELS, R ;
MOMMEN, P ;
PAESMANS, M .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (09) :1556-1562
[3]  
*NONSM CELL LUNG C, 1995, BMJ-BRIT MED J, V31, P899
[4]   PHASE-II RANDOMIZED TRIAL COMPARING HIGH-DOSE CISPLATIN WITH MODERATE-DOSE CISPLATIN AND CARBOPLATIN IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER [J].
SCULIER, JP ;
KLASTERSKY, J ;
GINER, V ;
BUREAU, G ;
THIRIAUX, J ;
DABOUIS, G ;
EFREMIDIS, A ;
RIES, F ;
BERCHIER, MC ;
SERGYSELS, R ;
MOMMEN, P ;
PAESMANS, M .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (02) :353-359
[5]   A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer [J].
Sculier, JP ;
Paesmans, M ;
Thiriaux, J ;
Lecomte, J ;
Bureau, G ;
Giner, V ;
Koumakis, G ;
Lafitte, JJ ;
Berchier, MC ;
Alexopoulos, CG ;
Zacharias, C ;
Mommen, P ;
Ninane, V ;
Klastersky, J .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (09) :1314-1319
[6]   Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer [J].
Sculier, JP ;
Lafitte, JJ ;
Paesmans, M ;
Thiriaux, J ;
Alexopoulos, CG ;
Baumöhl, J ;
Schmerber, J ;
Koumakis, G ;
Florin, MC ;
Zacharias, C ;
Berghmans, T ;
Mommen, P ;
Ninane, V ;
Klastersky, J .
BRITISH JOURNAL OF CANCER, 2000, 83 (09) :1128-1135